“…To clarify the last exclusion criterion, it is important to note that there is a significant body of literature that focuses on the mechanical behaviour of primary stability, which is an important risk factor for the AL of cementless hip implants. And evidence was found that early peri-implant bone healing immediately after implantation and the consequent mechanical remodelling at the bone-implant interface are essential for secondary implant stability [45,46]. However, it is the secondary stability that directly leads to the occurrence of AL.…”
Aseptic loosening is the most common failure mode for total hip arthroplasty, and the design of the implant plays a significant role in influencing the longevity and stability of the implant. Finite Element (FE) models have been demonstrated to be powerful numerical tools that allow for generating information supporting the device’s safety and/or efficacy during pre-clinical assessment. Different authors have proposed FE studies aiming to simulate the long-term stability of the femoral stem; however, multiple improvements are still necessary for translating computational methodologies into clinical practice. This paper provides a comprehensive overview of the modelling procedures for predicting aseptic loosening risk, focusing on cementless femoral stems. The main modelling assumptions, including bone and implant geometry, materials, boundary conditions, and bone–implant interface contact, were summarised and presented. The limitations of various modelling assumptions and their impact on the simulation results were also discussed. The analysis suggests that more rigorous clinical validation for osseointegration models and failure criteria used to determine loosening of the implant should be clearly defined, and efforts should be made to identify the appropriate limit of tolerable conditions.
“…To clarify the last exclusion criterion, it is important to note that there is a significant body of literature that focuses on the mechanical behaviour of primary stability, which is an important risk factor for the AL of cementless hip implants. And evidence was found that early peri-implant bone healing immediately after implantation and the consequent mechanical remodelling at the bone-implant interface are essential for secondary implant stability [45,46]. However, it is the secondary stability that directly leads to the occurrence of AL.…”
Aseptic loosening is the most common failure mode for total hip arthroplasty, and the design of the implant plays a significant role in influencing the longevity and stability of the implant. Finite Element (FE) models have been demonstrated to be powerful numerical tools that allow for generating information supporting the device’s safety and/or efficacy during pre-clinical assessment. Different authors have proposed FE studies aiming to simulate the long-term stability of the femoral stem; however, multiple improvements are still necessary for translating computational methodologies into clinical practice. This paper provides a comprehensive overview of the modelling procedures for predicting aseptic loosening risk, focusing on cementless femoral stems. The main modelling assumptions, including bone and implant geometry, materials, boundary conditions, and bone–implant interface contact, were summarised and presented. The limitations of various modelling assumptions and their impact on the simulation results were also discussed. The analysis suggests that more rigorous clinical validation for osseointegration models and failure criteria used to determine loosening of the implant should be clearly defined, and efforts should be made to identify the appropriate limit of tolerable conditions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.